Zomegipral belongs to a group of medicines called proton pump inhibitors. Zomegipral contains the active ingredient Esomeprazole. Zomegipral works by decreasing the amount of acid that is made by the stomach. Zomegipral used to treat:
1.GERD disease: This disease is caused by food and acid flowing from the stomach the wrong way up (reflux) back into the food pipe, also known as the esophagus. Reflux can cause a burning sensation in the chest that reaches up to the throat, also known as heartburn. Zomegipral is used to treat reflux esophagitis, and is also used to help prevent reflux esophagitis from coming back or recurring.
2.Peptic ulcer: Depending on the location of the ulcer, it is called a stomach or duodenal ulcer. Stomach ulcers occur in the stomach. Duodenal ulcers occur in the duodenum, which is the tube that leads out of the stomach. These ulcers can be caused by too much acid in the stomach. Most people with peptic ulcers also have bacteria called Helicobacter pylori in their stomach. When treating peptic ulcers associated with H. pylori, Zomegipral is used in combination with two antibiotics (clarithromycin and amoxicillin). When Zomegipral is taken with antibiotics, the combination treatment will kill H. pylori and allow the ulcer to heal. Zomegipral is used to treat peptic ulcers, and is also used to help prevent peptic ulcers from coming back or recurring.
3.Chronic gastritis: The presence of Helicobacter pylori (H. pylori) may lead to gastritis, leading to pain, nausea, and vomiting. When Zomegipral taken with antibiotics, they will help kill the H. pylori bacteria and allow the stomach to heal.
What you should know about Zomegipral
This medication is well tolerated by the body, and most people do not feel or experience any serious side effects. The most common side effects are headache and gastrointestinal upset, and these often go away with continued treatment.
The usual dose is once daily (however the doctor can increase the dose to twice daily), the dose is taken either 30 minutes before breakfast or 30 minutes before dinner, and the duration of treatment in most cases is between 4 to 8 weeks. Your doctor may ask you to continue taking this medication for longer periods. Always follow your doctor’s instructions.
Regular use of Zomegipral for prolonged periods (once daily for more than 6 to 12 months) may lead to the following problems: ① increased risk of bone fractures, especially in elderly patients with osteoporosis ② decreased levels of magnesium in the blood, and this can lead to Heart rhythm disturbances, ③ deficiency of vitamin B in the body, which may lead to anemia.
Treatment with Zomegipral may mask stomach cancer (a disease in which malignant (cancerous) cells form in the lining of the stomach)…Therefore, the presence of stomach cancer must be ruled out before starting treatment with Zomegipral, noting that improvement in symptoms does not prevent the presence of stomach malignancy.
Long-term treatment with esomeprazole has been associated with atrophic gastritis (changes in the type of cells lining the stomach wall, which is characterized by chronic inflammation of the gastric mucosa).
Treatment with Zomegipral, especially for a prolonged period of time, may be associated with an increased risk of diarrhea caused by C. difficile, a bacteria that causes severe diarrhea, and inflammation of the colon, a condition called pseudomembranous colitis.
Bone fracture: Long-term treatment may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine.
High doses of esomeprazole reduce the anti-platelet activity of clopidogrel (Plavix).
Hypomagnesaemia has been reported rarely with prolonged treatment with proton pump inhibitors.
Avoid concomitant use of Zomegipral with St. John’s wort or rifampin due to the possibility of a decrease in the effect of esomeprazole.
DOSAGE AND ADMINISTRATION
Zomegipral is supplied as delayed-release capsules for oral administration or in packets for preparation of delayed-release oral suspensions.
The recommended dosages are outlined in table below.
Zomegipral should be taken at least one hour before meals.
The duration of proton pump inhibitor administration should be based on available safety and efficacy data specific to the defined indication and dosing frequency, as described in the prescribing information, and individual patient medical needs.
Proton pump inhibitor treatment should only be initiated and continued if the benefits outweigh the risks of treatment.
Recommended Dosage Schedule for Zomegipral
|Gastroesophageal Reflux Disease (GERD)|
|Healing of Erosive Esophagitis||40 mg||Once Daily for 4 to 8 Weeks|
|Pediatric GERD 12 to 17 Years Old|
|Symptomatic Gastroesophageal Reflux Disease||40 mg||Once Daily for 4 to 8 Weeks|
|H.pylori Eradication to Reduce the risk of Duodenal Ulcer Recurrence|
|for 10 days
|Pathological Hypersecretory Conditions Including Zollinger Ellison Syndrome||40 mg||twice daily|
Delayed-Release Capsules – Route: Oral
Capsule can be swallowed whole. -or- Capsule can be opened and mixed with applesauce
Delayed-Release Capsules – Route: Nasogastric Tube
Capsule can be opened and the intact granules emptied into a syringe and delivered through the nasogastric tube.
Zomegipral Delayed-Release Capsules
Zomegipral Delayed-Release Capsules should be swallowed whole.
Alternatively, for patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Zomegipral Delayed-Release Capsule can be opened, and the granules inside the capsule carefully emptied onto the applesauce.
- The granules should be mixed with the applesauce and then swallowed immediately.
- Do not store for future use.
- The applesauce used should not be hot and should be soft enough to be swallowed without chewing.
- The granules should not be chewed or crushed.
- If the granules/applesauce mixture is not used in its entirety, the remaining mixture should be discarded immediately.
For patients who have a nasogastric tube in place, Zomegipral Delayed-Release Capsules can be opened and the intact granules emptied into a 60 ml catheter tipped syringe and mixed with 50 ml of water. It is important to only use a catheter tipped syringe when administering Zomegipral through a nasogastric tube.
Replace the plunger and shake the syringe vigorously for 15 seconds. Hold the syringe with the tip up and check for granules remaining in the tip. Attach the syringe to a nasogastric tube and deliver the contents of the syringe through the nasogastric tube into the stomach.
- After administering the granules, the nasogastric tube should be flushed with additional water.
- Do not administer the granules if they have dissolved or disintegrated.
- The mixture must be used immediately after preparation.
common side effects (may affect 1 in 10 people who use this medicine)
- Diarrhea, stomach pain, constipation, wind (flatulence).
- Nausea or vomiting.
Zomegipral is an equivalent alternative to the Esmorap brand. For more information, I advise you to read the patient information leaflet of Esmorap.
Product reference code: A02BC05.